3247. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise children and adolescents with heterozygous familial hypercholesterolaemia (HeFH) and understand current approaches to the identification and management of familial hypercholesterolaemia to inform future public health strategies.
3251. Perinatal morbidity among women with a previous caesarean delivery (PRISMA trial): a cluster-randomised trial.
作者: Nils Chaillet.;Benoît Mâsse.;William A Grobman.;Allison Shorten.;Robert Gauthier.;Patrick Rozenberg.;Marylène Dugas.;Jean-Charles Pasquier.;François Audibert.;Haim A Abenhaim.;Suzanne Demers.;Bruno Piedboeuf.;William D Fraser.;Robert Gagnon.;Guy-Paul Gagné.;Diane Francoeur.;Isabelle Girard.;Louise Duperron.;Marie-Josée Bédard.;Mira Johri.;Eric Dubé.;Simon Blouin.;Thierry Ducruet.;Mario Girard.;Emmanuel Bujold.; .
来源: Lancet. 2024年403卷10421期44-54页
Women with a previous caesarean delivery face a difficult choice in their next pregnancy: planning another caesarean or attempting vaginal delivery, both of which are associated with potential maternal and perinatal complications. This trial aimed to assess whether a multifaceted intervention, which promoted person-centred decision making and best practices, would reduce the risk of major perinatal morbidity among women with one previous caesarean delivery.
3253. Tackling health emergencies in complex settings: the role of national public health institutes in the Eastern Mediterranean region.
作者: Wasiq Khan.;Aamer Ikram.;Sara Hersey.;John Grundy.;Sadaf Lynes.;Mamunur Malik.;Awad Mataria.;Richard Brennan.
来源: Lancet. 2024年403卷10421期8-10页 3256. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
作者: David J Jackson.;Liam G Heaney.;Marc Humbert.;Brian D Kent.;Anat Shavit.;Lina Hiljemark.;Lynda Olinger.;David Cohen.;Andrew Menzies-Gow.;Stephanie Korn.; .
来源: Lancet. 2024年403卷10423期271-281页
Stepwise intensification of inhaled corticosteroids (ICS) is routine for severe eosinophilic asthma, despite some poor responses to high-dose ICS. Dose reductions are recommended in patients responding to biologics, but little supporting safety evidence exists.
3257. Chagas disease.
作者: Andréa Silvestre de Sousa.;Debbie Vermeij.;Alberto Novaes Ramos.;Alejandro O Luquetti.
来源: Lancet. 2024年403卷10422期203-218页
Chagas disease persists as a global public health problem due to the high morbidity and mortality burden. Despite the possibility of a cure and advances in transmission control, epidemiological transformations, such as urbanisation and globalisation, and the emerging importance of oral and vertical transmission mean that Chagas disease should be considered an emerging disease, with new cases occurring worldwide. Important barriers to diagnosis, treatment, and care remain, resulting in repressed numbers of reported cases, which in turn leads to inadequate public policies. The validation of new diagnostic tools and treatment options is needed, as existing tools pose serious limitations to access to health care. Integrated models of surveillance, with community and intersectional participation, embedded in the concept of One Health, are essential for control. In addition, mitigation strategies for the main social determinants of health, including difficulties imposed by migration, are important to improve access to comprehensive health care in a globalised scenario.
|